Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University of Arizona
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients diagnosed with high risk malignant melanoma (defined as American Joint Committee on Cancer Stage IIb or greater) electing to undergo treatment with either adjuvant interferon alpha-2b, or observation only.
Age 18 years or older.
Karnofsky performance status greater than 60.
Fluent English speaker.
You may not be if
History of neurologic or psychiatric disease that will affect patient's ability to complete protocol tests.
Clinical or radiological evidence of brain metastasis.
Any condition, which in the opinion of the investigator makes the subject unsuitable for study participation.
